Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 October 2019 | Story Xolisa Mnukwa | Photo Charl Devenish
Gradstar UFS
The 2019 GradStar programme is all about producing well-rounded students and providing them with opportunities in the world of work, explained Head of UFS Career Services, Belinda Janeke.

Congratulations to the Kovsies top-11 students who made it into the GradStar top-100 programme for 2019!

Each year, 100 South African students are selected through a rigorous four-phase judging process to become part of the GradStar programme. The programme is designed to offer opportunities for employment to previously unrecognised students.

What makes the top 11? 

According to the UFS Head of Career Services, Belinda Janeke, the GradStar programme is all about producing a well-rounded student. Approximately 6 000 applications were received from Kovsies, of which 500 were selected based on a personality test. Another test was given to the 500 students who passed the personality test, after which interviews were conducted to determine the top 100 from the UFS.  

The students who were selected to represent the UFS exhibited the most potential as future leaders in their respective fields. Apart from academic achievement, contestants were evaluated according to their individual soft skills such as motivation, discipline, altruism, and attitude. This combination promised to deliver top candidates for future employers. 

2019 GradStar programme experiences

Throughout the competition, Kovsie contestants were exposed to new people and opportunities to network with various companies in their preferred career fields, where they had the opportunity to share their CVs with potential employers. Contestants were also afforded the opportunity to develop critical problem-solving skills in the world of work. The GradStar top-100 students also have a WhatsApp group where jobs are advertised.

The programme was valuable for the Kovsies; not only did it prepare them for employment, but also provided them with an opportunity for learning and recognising their own strengths and weaknesses as individuals in the working world. 

Congratulations to the Kovsies who made it into the GradStar top 100: 

Mariné du Toit: Bachelor of Social Work
Nyiko Maluleka: Bachelor of Arts, Corporate and Marketing Communication
Bianca Malan: Bachelor of Accounting, Financial Accounting
Boitumelo Mancoe: Master of Business Administration
Kabelo Mashego: Bachelor of Medicine and Bachelor of Surgery (MB ChB)
Kananelo Moletsane: Bachelor of Agriculture
Mudzunga Mukwevho: Bachelor of Accounting, Financial Accounting
Neo Roberts: Bachelor of Science, Information Technology 
Refilwe Maimane: Bachelor of Commerce, Accounting 
Themba Makhoba: Bachelor of Public Administration
Mpolokeng Mmutle: Bachelor of Commerce, Accounting

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept